CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Biogen-backed Estuary nabs $93M for kidney disease gene therapy

Positive
AI Analysis

Summary

Biogen-backed Estuary raised $93M in financing to develop a gene therapy for kidney disease.

Outcome Details

Estuary raised $93M, backed by Biogen, to advance a kidney disease gene therapy.

Importance:5/10
Sentiment:
0.40
financinggene therapykidney diseaseprivate companyBiogen
Related Companies

Read the original article

Published by yahoo_finance on October 16, 2026 10:30 AM

Read Original